Anticoagulant therapy in COVID‐19: A narrative review

Coronavirus disease 2019 (COVID‐19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), can manifest itself in several ways, including coagulopathy and thrombosis. These complications can be the first and sometimes only manifestations of SARS‐CoV‐2 infection and can occur ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohseni Afshar, Zeinab, Tavakoli Pirzaman, Ali, Hosseinzadeh, Rezvan, Babazadeh, Arefeh, Taghizadeh Moghadam, Mohamad Ali, Miri, Seyed Rouhollah, Sio, Terence T., Sullman, Mark J. M., Barary, Mohammad, Ebrahimpour, Soheil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499427/
https://www.ncbi.nlm.nih.gov/pubmed/37326220
http://dx.doi.org/10.1111/cts.13569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499427/
https://www.ncbi.nlm.nih.gov/pubmed/37326220
http://dx.doi.org/10.1111/cts.13569

Ejemplares similares